Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2‐negative breast cancer patients in Israel: A registry analysis-Reference-Cited by-同舟云学术

Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2‐negative breast cancer patients in Israel: A registry analysis

Published:2020-05-18 Issue:10 Volume:26 Page:2096-2098
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Bar-Sela Gil¹,Samih Yousef¹,Yerushalmi Rinat²³,Leviov Michelle⁴,Efrat Ben‐Baruch Noa⁵,Kuchuk Iryna⁶,Tokar Margarita⁷,Peretz‐Yablonski Tamar⁸,Sonnenblick Amir³⁹^ORCID,Soussan‐Gutman Lior¹⁰,Bareket‐Samish Avital¹¹^ORCID,Fried Georgeta¹²,Paluch‐Shimon Shani¹³,Kaufman Bella¹⁴,Hammerman Ariel¹⁵,Liebermann Nicky¹⁵,Stemmer Salomon M.²³

Affiliation:

1. Ha’emek Medical Center Afula Israel

2. Davidoff Center Rabin Medical Center Petah Tikva Israel

3. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

4. Lin Medical Center Haifa Israel

5. Kaplan Medical Center Rehovot Israel

6. Meir Medical Center Kfar Saba Israel

7. Soroka University Medical Center and The Faculty of Health Sciences Ben‐Gurion University of the Negev Beer‐Sheva Israel

8. Hadassah‐Hebrew University Medical Center Jerusalem Israel

9. Tel‐Aviv Sourasky Medical center Tel Aviv Israel

10. Oncotest‐Rhenium Modiin Israel

11. BioInsight Ltd Binyamina Israel

12. Rambam Health‐Care Campus Haifa Israel

13. Shaare Zedek Medical Center Jerusalem Israel

14. The Chaim Sheba Medical Center Tel Hashomer Ramat Gan Israel

15. Community Division Clalit Health Services Tel Aviv Israel

Funder

Oncotest

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13870

Reference8 articles.

1. Race, ethnicity and clinical outcomes in hormone receptor‐positive, HER2‐negative, node‐negative breast cancer: results from the TAILORx trial;Albain K;Cancer Res,2019

2. Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

3. The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer

4. Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor–Positive, Node-Negative Breast Cancer

5. Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry;npj Breast Cancer;2023-09-30

2. Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study;npj Breast Cancer;2023-06-02